DK1631298T3 - Glykosaminoglykaner til behandling af emotionelle funktionsforstyrrelser - Google Patents
Glykosaminoglykaner til behandling af emotionelle funktionsforstyrrelserInfo
- Publication number
- DK1631298T3 DK1631298T3 DK04741606T DK04741606T DK1631298T3 DK 1631298 T3 DK1631298 T3 DK 1631298T3 DK 04741606 T DK04741606 T DK 04741606T DK 04741606 T DK04741606 T DK 04741606T DK 1631298 T3 DK1631298 T3 DK 1631298T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- glycosaminoglycans
- emotional disorders
- disorders
- anxiety
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT001023A ITMI20031023A1 (it) | 2003-05-21 | 2003-05-21 | Glicosaminoglicani aventi peso molecolare medio 2400 d atti al trattamento delle disfunzioni emozionali. |
| PCT/EP2004/050860 WO2004103381A1 (en) | 2003-05-21 | 2004-05-19 | Glycosaminoglycans for treatment emotional dysfunctions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1631298T3 true DK1631298T3 (da) | 2008-01-28 |
Family
ID=30131059
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04741606T DK1631298T3 (da) | 2003-05-21 | 2004-05-19 | Glykosaminoglykaner til behandling af emotionelle funktionsforstyrrelser |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US7812005B2 (da) |
| EP (1) | EP1631298B8 (da) |
| JP (1) | JP4757197B2 (da) |
| KR (1) | KR20060025142A (da) |
| CN (1) | CN100377717C (da) |
| AT (1) | ATE373480T1 (da) |
| AU (1) | AU2004241748B2 (da) |
| CA (1) | CA2526201A1 (da) |
| DE (1) | DE602004009068T2 (da) |
| DK (1) | DK1631298T3 (da) |
| ES (1) | ES2294507T3 (da) |
| HK (1) | HK1084023A1 (da) |
| IL (1) | IL171981A (da) |
| IT (1) | ITMI20031023A1 (da) |
| NO (1) | NO20056089L (da) |
| NZ (1) | NZ544238A (da) |
| PL (1) | PL1631298T3 (da) |
| PT (1) | PT1631298E (da) |
| RU (1) | RU2353371C2 (da) |
| WO (1) | WO2004103381A1 (da) |
| ZA (1) | ZA200510132B (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101584704B (zh) * | 2008-05-23 | 2010-12-15 | 鲁南制药集团股份有限公司 | 肝素、低分子肝素可药用盐或其衍生物的医药用途 |
| CN106282122B (zh) * | 2016-08-23 | 2020-10-02 | 中国科学院上海药物研究所 | 一种非人哺乳动物恐惧症或其相关疾病动物模型的建立方法及其用途 |
| CN112438991B (zh) * | 2019-08-29 | 2024-03-15 | 鲁南制药集团股份有限公司 | 肝素、或其衍生物、或其可药用盐的医药用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4351938A (en) * | 1980-05-19 | 1982-09-28 | Riker Laboratories, Inc. | Anticoagulant substance |
| US4916219A (en) * | 1985-03-28 | 1990-04-10 | University Of Iowa Research Foundation | Oligosaccharide heparin fragments as inhibitors of complement cascade |
| IT1205042B (it) * | 1987-05-28 | 1989-03-10 | Crinos Industria Farmaco | Composizione farmaceutica ad attivita' terapeutica per il trattamento della demenza senile di tipo alzheimer |
| US5605938A (en) | 1991-05-31 | 1997-02-25 | Gliatech, Inc. | Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate |
| FR2763848B1 (fr) * | 1997-05-28 | 2000-01-28 | Rhone Poulenc Rorer Sa | Utilisation des heparines de bas poids moleculaire pour la prevention et le traitement du trauma du systeme nerveux central |
| FR2763849B1 (fr) * | 1997-05-28 | 2000-09-15 | Rhone Poulenc Rorer Sa | Utilisation des heparines de bas poids moleculaire pour la prevention et le traitement des oedemes cerebraux |
| JP4412756B2 (ja) * | 1998-02-26 | 2010-02-10 | 生化学工業株式会社 | 新規多糖誘導体、その製造法及びそれを有効成分とする医薬組成物 |
| IT1312107B1 (it) * | 1999-05-14 | 2002-04-04 | Umberto Cornelli | Glicosaminoglicani aventi peso molecolare medio di 2400 d atti altrattamento della demenza senile |
-
2003
- 2003-05-21 IT IT001023A patent/ITMI20031023A1/it unknown
-
2004
- 2004-05-19 NZ NZ544238A patent/NZ544238A/en unknown
- 2004-05-19 AU AU2004241748A patent/AU2004241748B2/en not_active Expired - Fee Related
- 2004-05-19 DE DE602004009068T patent/DE602004009068T2/de not_active Expired - Fee Related
- 2004-05-19 PT PT04741606T patent/PT1631298E/pt unknown
- 2004-05-19 RU RU2005138517/15A patent/RU2353371C2/ru not_active IP Right Cessation
- 2004-05-19 ES ES04741606T patent/ES2294507T3/es not_active Expired - Lifetime
- 2004-05-19 US US10/557,860 patent/US7812005B2/en not_active Expired - Fee Related
- 2004-05-19 CN CNB2004800136097A patent/CN100377717C/zh not_active Expired - Fee Related
- 2004-05-19 WO PCT/EP2004/050860 patent/WO2004103381A1/en active IP Right Grant
- 2004-05-19 AT AT04741606T patent/ATE373480T1/de not_active IP Right Cessation
- 2004-05-19 CA CA002526201A patent/CA2526201A1/en not_active Abandoned
- 2004-05-19 KR KR1020057021781A patent/KR20060025142A/ko not_active Application Discontinuation
- 2004-05-19 JP JP2006530208A patent/JP4757197B2/ja not_active Expired - Fee Related
- 2004-05-19 DK DK04741606T patent/DK1631298T3/da active
- 2004-05-19 EP EP04741606A patent/EP1631298B8/en not_active Expired - Lifetime
- 2004-05-19 PL PL04741606T patent/PL1631298T3/pl unknown
-
2005
- 2005-11-15 IL IL171981A patent/IL171981A/en not_active IP Right Cessation
- 2005-12-13 ZA ZA200510132A patent/ZA200510132B/en unknown
- 2005-12-21 NO NO20056089A patent/NO20056089L/no not_active Application Discontinuation
-
2006
- 2006-04-07 HK HK06104250A patent/HK1084023A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2006528670A (ja) | 2006-12-21 |
| DE602004009068D1 (de) | 2007-10-31 |
| RU2005138517A (ru) | 2006-08-27 |
| ES2294507T3 (es) | 2008-04-01 |
| RU2353371C2 (ru) | 2009-04-27 |
| IL171981A (en) | 2010-04-15 |
| CN100377717C (zh) | 2008-04-02 |
| NO20056089L (no) | 2006-02-09 |
| PL1631298T3 (pl) | 2008-04-30 |
| ITMI20031023A0 (it) | 2003-05-21 |
| KR20060025142A (ko) | 2006-03-20 |
| US20060205690A1 (en) | 2006-09-14 |
| WO2004103381A1 (en) | 2004-12-02 |
| EP1631298B1 (en) | 2007-09-19 |
| ITMI20031023A1 (it) | 2004-11-22 |
| US7812005B2 (en) | 2010-10-12 |
| CA2526201A1 (en) | 2004-12-02 |
| EP1631298B8 (en) | 2008-12-24 |
| IL171981A0 (en) | 2006-04-10 |
| HK1084023A1 (en) | 2006-07-21 |
| CN1791416A (zh) | 2006-06-21 |
| EP1631298A1 (en) | 2006-03-08 |
| AU2004241748B2 (en) | 2010-05-13 |
| PT1631298E (pt) | 2007-12-31 |
| AU2004241748A1 (en) | 2004-12-02 |
| ZA200510132B (en) | 2006-08-30 |
| ATE373480T1 (de) | 2007-10-15 |
| DE602004009068T2 (de) | 2008-06-19 |
| JP4757197B2 (ja) | 2011-08-24 |
| NZ544238A (en) | 2008-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1110965T1 (el) | Επιπροσθετες ετεροπολυκυκλικες ενωσεις και η χρηση τους ως ανταγωνιστες μεταβολοτροπικου υποδοχεα γλουταμικου | |
| SE0301010D0 (sv) | Novel compounds | |
| MXPA05009015A (es) | Nuevos derivados de bencimidazol e imidazo-piridina y su utilizacion como medicamentos. | |
| SE0301009D0 (sv) | Novel compounds | |
| MXPA05009595A (es) | Compuestos 7-amino-isoindolilo y sus usos farmaceuticos. | |
| SE0301700D0 (sv) | Novel compounds | |
| MY143390A (en) | Sulfonamide derivatives for the treatment of diseases. | |
| TW200612905A (en) | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders | |
| TW200611702A (en) | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders | |
| MX2010003612A (es) | Derivados de oxadiazol. | |
| SE0301653D0 (sv) | Novel compounds | |
| IL188475A0 (en) | Pyrido [2,3-d]pyrimidine-2,4-diamine compounds as ptpib inhibitors | |
| GEP20084452B (en) | Sulfonamide derivatives for the treatment of diseases | |
| TW200718422A (en) | 1,6-Dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same | |
| SE0300119D0 (sv) | Novel compounds | |
| EA200601462A1 (ru) | Соединения для лечения заболеваний | |
| TW200716566A (en) | Prokineticin 2 receptor antagonists | |
| SE0302139D0 (sv) | Novel compounds | |
| TW200745122A (en) | New compounds I | |
| CY1109808T1 (el) | Αρυλινδενο-πυριδινες και αρυλινδενο-πυριμιδινες και η χρηση τους ως ανταγωνιστων των υποδοχεων αδενοσινης α2α | |
| MY147677A (en) | Piperazinyl derivatives useful in the treatment of gpr38 receptor mediated diseases | |
| SE0403171D0 (sv) | New compounds | |
| SE0402925D0 (sv) | Novel Compounds | |
| UY29999A1 (es) | "n-pirazinil-fenilsulfonamidas, procedimientos y compuestos intemedios utilizados en su preparacion, composiciones farmaceuticas que las contienen y aplicaciones" | |
| EA200701856A1 (ru) | Тетрагидропиридоазепин-8-оны и родственные соединения для лечения шизофрении |